Published in J Cell Physiol on August 01, 2013
Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol (2014) 0.99
Effect of probiotics supplementation on bone mineral content and bone mass density. ScientificWorldJournal (2014) 0.96
Loss of Bone and Wnt10b Expression in Male Type 1 Diabetic Mice Is Blocked by the Probiotic Lactobacillus reuteri. Endocrinology (2015) 0.85
Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome. Curr Osteoporos Rep (2015) 0.83
Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes (2013) 0.82
The intestinal microbiome and skeletal fitness: Connecting bugs and bones. Clin Immunol (2015) 0.82
Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-β signaling. BMC Microbiol (2015) 0.80
Probiotic supplementation promotes calcification in Danio rerio larvae: a molecular study. PLoS One (2013) 0.80
Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting. PLoS One (2016) 0.80
In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence. PLoS One (2016) 0.79
Gut microbiota induce IGF-1 and promote bone formation and growth. Proc Natl Acad Sci U S A (2016) 0.78
Links Between the Microbiome and Bone. J Bone Miner Res (2016) 0.78
Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiol (2016) 0.77
Doses Lactobacillus reuteri depend on adhesive ability to modulate the intestinal immune response and metabolism in mice challenged with lipopolysaccharide. Sci Rep (2016) 0.75
Influence of Synbiotics on Selected Oxidative Stress Parameters. Oxid Med Cell Longev (2017) 0.75
From the gut to the strut: where inflammation reigns, bone abstains. J Clin Invest (2016) 0.75
Microbial lysate upregulates host oxytocin. Brain Behav Immun (2016) 0.75
Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation. Stem Cell Res Ther (2017) 0.75
Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis. Bone Res (2017) 0.75
Gut Microbiome and Bone: to Build, Destroy, or Both? Curr Osteoporos Rep (2017) 0.75
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09
Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 6.37
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Reciprocal interactions of the intestinal microbiota and immune system. Nature (2012) 4.42
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
The gut microbiota regulates bone mass in mice. J Bone Miner Res (2012) 2.92
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 1.77
Gut, inflammation and osteoporosis: basic and clinical concepts. Gut (2008) 1.61
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem (2007) 1.48
The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res (1997) 1.42
A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr (2005) 1.41
Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.36
Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res (2007) 1.35
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A (2010) 1.33
Diabetic complications and dysregulated innate immunity. Front Biosci (2008) 1.28
Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.23
The immune system and bone. Arch Biochem Biophys (2010) 1.19
The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol Rev (2012) 1.13
Role of T cells in ovariectomy induced bone loss--revisited. J Bone Miner Res (2012) 1.09
The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol (2011) 1.05
The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis. Gastroenterology (2006) 1.02
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut (2005) 1.00
Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol (2009) 0.97
Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol (2009) 0.92
Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther (2005) 0.89
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87
Colitogenic CD4+ effector-memory T cells actively recirculate in chronic colitic mice. Inflamm Bowel Dis (2008) 0.85
Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis (2013) 0.84
Estrogen inhibits chloride secretion caused by cholera and Escherichia coli enterotoxins in female rat distal colon. Steroids (2011) 0.84
Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep (2011) 0.83
Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model. J Food Sci (2012) 0.82
Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures. Bone (2012) 0.78
Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. J Bacteriol (2003) 2.21
Maturation of the 5' end of Bacillus subtilis 16S rRNA by the essential ribonuclease YkqC/RNase J1. Mol Microbiol (2007) 2.10
Identification of AbrB-regulated genes involved in biofilm formation by Bacillus subtilis. Mol Microbiol (2004) 2.09
Incorporating genomics and bioinformatics across the life sciences curriculum. PLoS Biol (2010) 1.89
Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci U S A (2010) 1.59
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
The essential GTPase RbgA (YlqF) is required for 50S ribosome assembly in Bacillus subtilis. Mol Microbiol (2006) 1.47
Disruption of the COP9 signalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic death. Mol Cell Biol (2003) 1.46
Multiple GTPases participate in the assembly of the large ribosomal subunit in Bacillus subtilis. J Bacteriol (2006) 1.41
Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol (2008) 1.23
The essential GTPase YqeH is required for proper ribosome assembly in Bacillus subtilis. J Bacteriol (2007) 1.21
High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res (2012) 1.21
Earth's earliest atmospheres. Cold Spring Harb Perspect Biol (2010) 1.20
The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Appl Environ Microbiol (2007) 1.15
Structural maintenance of chromosomes protein of Bacillus subtilis affects supercoiling in vivo. J Bacteriol (2002) 1.14
The lactococcal phages Tuc2009 and TP901-1 incorporate two alternate forms of their tail fiber into their virions for infection specialization. J Biol Chem (2013) 1.11
The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology (2010) 1.05
The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol (2011) 1.05
Exploring optimization parameters to increase ssDNA recombineering in Lactococcus lactis and Lactobacillus reuteri. Bioengineered (2012) 1.01
Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol (2014) 0.99
Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol (2009) 0.97
Biochemical characterization of ribosome assembly GTPase RbgA in Bacillus subtilis. J Biol Chem (2012) 0.95
Functional domains of the 50S subunit mature late in the assembly process. Nucleic Acids Res (2013) 0.94
β-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol (2013) 0.93
Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun (2010) 0.93
Nuclear cGMP-dependent kinase regulates gene expression via activity-dependent recruitment of a conserved histone deacetylase complex. PLoS Genet (2011) 0.91
Global transcriptional response of Lactobacillus reuteri to the sourdough environment. Syst Appl Microbiol (2008) 0.91
Flux analysis of the Lactobacillus reuteri propanediol-utilization pathway for production of 3-hydroxypropionaldehyde, 3-hydroxypropionic acid and 1,3-propanediol from glycerol. Microb Cell Fact (2014) 0.89
Hypoxia suppresses runx2 independent of modeled microgravity. J Cell Physiol (2004) 0.89
Interactions of an essential Bacillus subtilis GTPase, YsxC, with ribosomes. J Bacteriol (2007) 0.88
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87
Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl Environ Microbiol (2008) 0.85
Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology (2014) 0.84
Gene dosage-dependent negative regulatory role of β-arrestin-2 in polymicrobial infection-induced inflammation. Infect Immun (2013) 0.84
Precision genome engineering in lactic acid bacteria. Microb Cell Fact (2014) 0.83
Mutational analysis of the ribosome assembly GTPase RbgA provides insight into ribosome interaction and ribosome-stimulated GTPase activation. Nucleic Acids Res (2013) 0.82
Glycerol supplementation enhances L. reuteri's protective effect against S. Typhimurium colonization in a 3-D model of colonic epithelium. PLoS One (2012) 0.81
Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis. Proc Natl Acad Sci U S A (2012) 0.78
The human microbiome and infectious diseases: beyond koch. Interdiscip Perspect Infect Dis (2009) 0.77
A practical synthesis of 5-lipoxygenase inhibitor MK-0633. J Org Chem (2010) 0.75
A steamy proposal for Martian clays. Nature (2017) 0.75